Language
AMRIT-ON
Institute for Strategic Biomedical Research
Who we are
AMRIT-ON is a private international research platform. Based on more than 20 years of scientific work, we develop innovative biologically oriented approaches in oncology, gerontology, regenerative medicine, and cardiovascular diseases.
Scientific & Clinical Status
Preclinical stage and early clinical phases: successfully completed.
0 1
Preclinical Research
Completed0 2
Phase I & II Clinical Trials
Completed0 3
Phase III Clinical Research
ActiveCurrent status: ongoing Phase III clinical evaluation. Protection & registration: international patent protection; officially registered oral nutraceutical form. Funding: independent and entirely private.
Core Research Areas
Our programs cover a broad spectrum of oncological diseases.
Solid tumors
including brain, breast, lung, colorectal, pancreatic, and prostate cancers, as well as melanoma.
Gynecological oncology
ovarian, cervical, and endometrial cancers.
Systemic and rare forms
lymphomas, leukemias, sarcomas, neuroendocrine tumors, and skin cancer.
Our Approach in Oncology
We combine translational oncology with integrative approaches. Our work is based on: biologically active natural compounds; multicomponent regulatory mechanisms; strictly personalized models.
Conceptual Research Model
Although we do not promise a universal cure, the observations and research data accumulated to date demonstrate impressive results and good tolerability, generating significant scientific interest.
Origin
National Academy of Sciences (NAS)
National Academy of Medical Sciences (NAMS)
Institute of Neurosurgery
For Clinics and Physicians
AMRIT-ON is not a mass-market product. We provide high-quality personalized biomedical solutions within individually adapted research programs under physician supervision.
Key Principles of Cooperation
Individual adaptation: the composition and configuration of the oral form are modified for each specific patient.
Exclusivity
limited production
continuous medical supervision
strict confidentiality
Pricing segment
due to the high complexity and intensive support involved, the programs belong to a high and ultra-premium pricing segment.
Cooperation opportunities
We are interested in cooperation with private clinics, oncology centers, and physicians for joint application and further research within our programs.
Authorized access includes clinical research data and private communication channel. Available exclusively under NDA.
International Network of Personalized Programs
Amrit-On is building an international system that brings together science, independent laboratories and clinical partners around each individual patient.
First — an individual laboratory assessment.Then — a decision.
When biopsy material is available, an individually selected composition can be studied on the patient's own biological material even before the program begins, with a laboratory assessment of its effectiveness and safety.
Where laboratory testing shows that the individually selected Amrit-On program demonstrates greater effectiveness compared with other tested therapy options, the patient, together with their treating physician, may decide to participate in the Institute's rehabilitation and recovery program.
From biological material to an individualized program
Biopsy
→Laboratory assessment and comparison
→Individualized composition
→Decision by physician and patient
→Personalized program
→Clinical support
Today the Amrit-On international network includes
Ukraine and Sweden
laboratory capabilities for studying the patient's biological material
Kyiv
implementation and clinical support of rehabilitation and recovery programs
Mobile medical teams
the possibility of organizing them anywhere in the world — in accordance with local legislation
Türkiye
when required, advanced diagnostics, surgery and subsequent recovery at a clinical partner
The geography of our partnership network continues to expand.
Amrit-On rehabilitation and recovery programs do not include chemotherapy or radiotherapy. The need for other treatment methods is determined by the patient together with their treating physician.
For Strategic Partners and Investors
AMRIT-ON is open to strategic partnerships with investors and biotech structures interested in investing in promising and innovative developments in biomedicine and oncology.
Additional information regarding the technology's capabilities, scientific data, and potential application formats will be provided individually to interested partners after defining a joint cooperation roadmap and under NDA.